Sunday, April 13, 2025

Technology | 2016.04.27

Allied Minds Announces Funding Commitments of Up to $80 million for the Development of Up to 10 Drug Discovery Programs

BOSTON--(BUSINESS WIRE)--Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, today announces that through its newly formed subsidiary, ABLS Capital, it has secured investment commitments of $80 million to fund up to ten potential lead optimization programs of promising drug development opportunities that have successfully completed an initial candidate feasibility program. Pursuant to the terms of the ABLS partnership formed between Alli

 

For more information, please visit
http://www.businesswire.com/news/home/20[...]itments-80-million-Development

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News